Lemzoparlimab (Anti-CD47)

Lemzoparlimab (anti-CD47) is a human monoclonal antibody targeting the human cell surface antigen CD47 with potential phagocytosis-inducing and antineoplastic activities. MW: 145.58 KD.
Supplier Selleck Chemicals
Product # A2921
Sku # A2921-1mg*25
Pricing 1mg*25, $2970.00
Feedback